Synthesis and anti-proliferative activity of allogibberic acid derivatives containing 1,2,3-triazole pharmacophore
- PMID: 29884535
- DOI: 10.1016/j.bmcl.2018.05.038
Synthesis and anti-proliferative activity of allogibberic acid derivatives containing 1,2,3-triazole pharmacophore
Abstract
Sixty novel allogibberic acid derivatives containing 1,2,3-triazole pharmacophore were designed and synthesized. The key chemical processes include aromatization of the A ring in gibberellins, formation of allogibberic azides and its copper mediated Huisgen 1,3-dipolar cycloaddition with alkynes. A number of hybrids containing α,β-unsaturated ketone moiety exhibited excellent in vitro cytotoxic activities. Some of the hybrids were more selective to MCF-7 and SW480 cell lines with IC50 values at least 8-fold more cytotoxic than cisplatin (DDP). The most potent compounds C43 and C45 are more cytotoxic than cisplatin (DDP) against all tested five tumor cell lines, with IC50 values of 0.25-1.72 µM. Mechanism of action studies indicated that allogibberic-triazole derivative C45 could induce the S phase cell cycle arrest and apoptosis in SMMC-7721 cell lines.
Keywords: 1,2,3-Triazole; Allogibberic acid; Apoptosis; Cell cycle; Cytotoxic activity.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.Bioorg Chem. 2020 May;98:103752. doi: 10.1016/j.bioorg.2020.103752. Epub 2020 Mar 12. Bioorg Chem. 2020. PMID: 32197148
-
Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.Eur J Med Chem. 2014 Oct 30;86:368-80. doi: 10.1016/j.ejmech.2014.08.010. Epub 2014 Aug 5. Eur J Med Chem. 2014. PMID: 25180925
-
Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.Eur J Med Chem. 2013 Apr;62:11-9. doi: 10.1016/j.ejmech.2012.12.046. Epub 2013 Jan 4. Eur J Med Chem. 2013. PMID: 23353743
-
Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies.Bioorg Chem. 2021 Oct;115:105184. doi: 10.1016/j.bioorg.2021.105184. Epub 2021 Jul 20. Bioorg Chem. 2021. PMID: 34333421 Review.
-
Bis-triazole-containing Compounds with Anticancer Potential: A Short Review.Curr Top Med Chem. 2021;21(18):1674-1691. doi: 10.2174/1568026621666210728154728. Curr Top Med Chem. 2021. PMID: 34323190 Review.
Cited by
-
Fluorinated triazoles as privileged potential candidates in drug development-focusing on their biological and pharmaceutical properties.Front Chem. 2022 Aug 9;10:926723. doi: 10.3389/fchem.2022.926723. eCollection 2022. Front Chem. 2022. PMID: 36017163 Free PMC article. Review.
-
Synthesis and Characterization of Bimetallic Nanoclusters Stabilized by Chiral and Achiral Polyvinylpyrrolidinones. Catalytic C(sp3)-H Oxidation.J Org Chem. 2022 May 20;87(10):6742-6759. doi: 10.1021/acs.joc.2c00449. Epub 2022 May 5. J Org Chem. 2022. PMID: 35511477 Free PMC article.
-
CuAAC-ensembled 1,2,3-triazole-linked isosteres as pharmacophores in drug discovery: review.RSC Adv. 2020 Feb 4;10(10):5610-5635. doi: 10.1039/c9ra09510a. eCollection 2020 Feb 4. RSC Adv. 2020. PMID: 35497465 Free PMC article. Review.
-
New Application of 1,2,4-Triazole Derivatives as Antitubercular Agents. Structure, In Vitro Screening and Docking Studies.Molecules. 2020 Dec 19;25(24):6033. doi: 10.3390/molecules25246033. Molecules. 2020. PMID: 33352814 Free PMC article.
-
Synthesis and In Vitro Cytotoxicity and Antibacterial Activity of Novel 1,2,3-Triazol-5-yl-phosphonates.Molecules. 2020 Jun 6;25(11):2643. doi: 10.3390/molecules25112643. Molecules. 2020. PMID: 32517229 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
